Have You Been Newly Diagnosed with Colon Cancer? Are You Struggling to Make Treatment Choices?

Then you may be interested to know that many patients with early-stage colon cancer do not benefit from chemotherapy. For some patients, chemotherapy may not add any significant medical advantage.

The Oncotype DX is a new, gene-based diagnostic test that can help men and women with some types of colon cancer learn more about the biological features of their specific tumor and help indicate how likely it is that a patient’s cancer may return in the future (recurrence). Coupled with other pieces of information, the results from the Oncotype DX test can help patients and their doctors make personalized decisions about whether or not to include chemotherapy in their treatment plan.